---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-23-000052"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:49:39.914279+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aspira appoints director, new CFO; regains Nasdaq bid price compliance

## Summary
- Dr. Winfred Parnell appointed to board effective June 1, 2023; also named to Nominating & Governance Committee.
- Interim CFO Marlene McLennan's term ended May 31, 2023; Dr. Torsten Hombeck to assume CFO role June 15, 2023.
- Regained Nasdaq compliance: closing bid price >=$1 for 10 consecutive days through May 25, 2023; matter closed.
- Previously disclosed deficiency in June 2022; extension granted until May 29, 2023 was met.
- Board determined Parnell meets Nasdaq independence standards.

## SEC filing metadata
- accession: 0000926617-23-000052
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/awh-20230526x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-23-000052
- JSON: https://secwatch.observer/filing/0000926617-23-000052.json
- Plain text: https://secwatch.observer/filing/0000926617-23-000052.txt

## Key facts
- Executive change
  Dr. Torsten Hombeck was appointed as Chief Financial Officer at Aspira Women's Health Inc..
  - Action: will begin his service
  - Role: Chief Financial Officer
  source text: As previously announced, Dr. Torsten Hombeck will begin his service as the Company’s Chief Financial Officer on June 15, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm
- Executive change
  Marlene McLennan departed as Interim Chief Financial Officer at Aspira Women's Health Inc..
  - Action: has come to a close
  - Role: Interim Chief Financial Officer
  source text: Effective May 31, 2023, Marlene McLennan’s term as Interim Chief Financial Officer of Aspira Women’s Health Inc. (the “Company”) has come to a close, pursuant to her Employment Agreement with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm
- Executive change
  Dr. Winfred Parnell was appointed as director at Aspira Women's Health Inc..
  - Action: appointed
  - Role: director
  source text: On June 1, 2023, the Company’s Board of Directors (the “Board”) appointed Dr. Winfred Parnell as a director, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.